Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colonoscopy | 13 | 2022 | 1410 | 2.290 |
Why?
|
Colitis, Ulcerative | 29 | 2024 | 1926 | 1.950 |
Why?
|
Crohn Disease | 23 | 2024 | 2294 | 1.490 |
Why?
|
Colorectal Neoplasms | 13 | 2024 | 6982 | 1.210 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2016 | 888 | 0.900 |
Why?
|
Gastrointestinal Hemorrhage | 4 | 2022 | 1126 | 0.880 |
Why?
|
Cathartics | 2 | 2022 | 129 | 0.870 |
Why?
|
Early Detection of Cancer | 12 | 2024 | 3238 | 0.860 |
Why?
|
Guideline Adherence | 3 | 2019 | 2241 | 0.820 |
Why?
|
Colitis, Microscopic | 5 | 2022 | 71 | 0.820 |
Why?
|
Adenoma | 5 | 2021 | 2163 | 0.740 |
Why?
|
Adenomatous Polyps | 1 | 2019 | 109 | 0.610 |
Why?
|
Inflammatory Bowel Diseases | 9 | 2023 | 2442 | 0.560 |
Why?
|
Colonic Polyps | 2 | 2019 | 557 | 0.540 |
Why?
|
Hepatic Encephalopathy | 1 | 2017 | 144 | 0.530 |
Why?
|
Proctocolitis | 1 | 2016 | 31 | 0.520 |
Why?
|
Mesalamine | 1 | 2016 | 134 | 0.500 |
Why?
|
Telenursing | 1 | 2014 | 2 | 0.490 |
Why?
|
Quality Indicators, Health Care | 4 | 2019 | 1812 | 0.480 |
Why?
|
Adenocarcinoma | 3 | 2019 | 6401 | 0.480 |
Why?
|
Nurse Anesthetists | 1 | 2014 | 24 | 0.460 |
Why?
|
Liver Cirrhosis | 4 | 2021 | 1962 | 0.460 |
Why?
|
Cecal Neoplasms | 1 | 2014 | 27 | 0.460 |
Why?
|
Digestive System Diseases | 1 | 2016 | 152 | 0.460 |
Why?
|
Helicobacter pylori | 2 | 2017 | 380 | 0.450 |
Why?
|
Helicobacter Infections | 2 | 2017 | 390 | 0.450 |
Why?
|
International Normalized Ratio | 1 | 2015 | 382 | 0.450 |
Why?
|
Outpatients | 2 | 2019 | 1603 | 0.440 |
Why?
|
Deep Sedation | 1 | 2014 | 119 | 0.420 |
Why?
|
Endoscopy, Digestive System | 1 | 2015 | 358 | 0.410 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2020 | 2276 | 0.400 |
Why?
|
Gastroenterology | 2 | 2018 | 593 | 0.400 |
Why?
|
Heart-Assist Devices | 1 | 2022 | 1292 | 0.380 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 520 | 0.370 |
Why?
|
Telephone | 1 | 2014 | 630 | 0.370 |
Why?
|
Endosonography | 1 | 2014 | 626 | 0.350 |
Why?
|
Microsatellite Instability | 1 | 2014 | 726 | 0.350 |
Why?
|
Inpatients | 2 | 2022 | 2569 | 0.350 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1204 | 0.330 |
Why?
|
Continuity of Patient Care | 2 | 2020 | 1076 | 0.310 |
Why?
|
Colonic Neoplasms | 3 | 2020 | 2543 | 0.300 |
Why?
|
Conscious Sedation | 1 | 2012 | 534 | 0.290 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2297 | 0.290 |
Why?
|
Celiac Disease | 3 | 2021 | 820 | 0.280 |
Why?
|
Warfarin | 1 | 2015 | 1493 | 0.280 |
Why?
|
Patient Readmission | 2 | 2020 | 3313 | 0.280 |
Why?
|
Incidence | 23 | 2024 | 21547 | 0.270 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2014 | 954 | 0.270 |
Why?
|
Acute Disease | 1 | 2017 | 7245 | 0.270 |
Why?
|
Electronic Health Records | 3 | 2015 | 4879 | 0.270 |
Why?
|
Diffusion of Innovation | 1 | 2011 | 732 | 0.260 |
Why?
|
Hypnotics and Sedatives | 1 | 2014 | 1191 | 0.260 |
Why?
|
Prospective Studies | 36 | 2023 | 54962 | 0.260 |
Why?
|
Insurance Coverage | 1 | 2017 | 1946 | 0.260 |
Why?
|
Quality Improvement | 3 | 2020 | 3860 | 0.250 |
Why?
|
Humans | 83 | 2024 | 768970 | 0.250 |
Why?
|
Risk Factors | 33 | 2024 | 74976 | 0.240 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7460 | 0.230 |
Why?
|
Middle Aged | 45 | 2024 | 223737 | 0.230 |
Why?
|
Mass Screening | 4 | 2021 | 5457 | 0.230 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 2763 | 0.220 |
Why?
|
Length of Stay | 1 | 2017 | 6526 | 0.220 |
Why?
|
Telemedicine | 1 | 2021 | 3110 | 0.220 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2911 | 0.220 |
Why?
|
Aged | 29 | 2024 | 171786 | 0.210 |
Why?
|
Female | 54 | 2024 | 397515 | 0.210 |
Why?
|
Anesthesia | 1 | 2014 | 1596 | 0.210 |
Why?
|
Contraceptives, Oral | 2 | 2018 | 561 | 0.210 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2020 | 388 | 0.210 |
Why?
|
Decision Support Systems, Clinical | 1 | 2012 | 1178 | 0.210 |
Why?
|
Adult | 40 | 2024 | 223851 | 0.200 |
Why?
|
Time Factors | 10 | 2019 | 40261 | 0.190 |
Why?
|
Quality of Health Care | 1 | 2017 | 4339 | 0.190 |
Why?
|
Tooth Loss | 1 | 2023 | 200 | 0.190 |
Why?
|
Cecum | 1 | 2022 | 231 | 0.190 |
Why?
|
Retrospective Studies | 12 | 2022 | 81903 | 0.190 |
Why?
|
Ambulatory Care | 1 | 2012 | 2784 | 0.190 |
Why?
|
Information Literacy | 1 | 2020 | 11 | 0.180 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2024 | 301 | 0.180 |
Why?
|
Aspirin | 3 | 2020 | 3135 | 0.180 |
Why?
|
Rectal Diseases | 1 | 2022 | 142 | 0.180 |
Why?
|
Primary Health Care | 3 | 2024 | 4748 | 0.180 |
Why?
|
Bhutan | 3 | 2017 | 61 | 0.180 |
Why?
|
Physicians, Primary Care | 2 | 2024 | 625 | 0.180 |
Why?
|
Diet Surveys | 3 | 2020 | 1160 | 0.170 |
Why?
|
Patient Selection | 1 | 2012 | 4265 | 0.170 |
Why?
|
Male | 30 | 2024 | 365203 | 0.170 |
Why?
|
Glutens | 2 | 2021 | 240 | 0.170 |
Why?
|
Periodontal Diseases | 1 | 2023 | 455 | 0.170 |
Why?
|
Antibodies, Bacterial | 2 | 2017 | 1478 | 0.170 |
Why?
|
Intestinal Mucosa | 3 | 2020 | 3044 | 0.170 |
Why?
|
Quality of Life | 1 | 2021 | 13510 | 0.160 |
Why?
|
Proportional Hazards Models | 14 | 2024 | 12562 | 0.160 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2022 | 241 | 0.160 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5804 | 0.160 |
Why?
|
Ascites | 1 | 2021 | 338 | 0.160 |
Why?
|
Estrogen Replacement Therapy | 2 | 2018 | 1209 | 0.160 |
Why?
|
Medicare | 1 | 2017 | 6888 | 0.160 |
Why?
|
Aged, 80 and over | 12 | 2024 | 59739 | 0.160 |
Why?
|
Colitis, Lymphocytic | 1 | 2018 | 23 | 0.150 |
Why?
|
Colitis, Collagenous | 1 | 2018 | 25 | 0.150 |
Why?
|
Heart Failure | 1 | 2022 | 11879 | 0.150 |
Why?
|
Dietary Fats | 2 | 2017 | 2002 | 0.150 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2022 | 554 | 0.140 |
Why?
|
Dinoprostone | 1 | 2020 | 597 | 0.140 |
Why?
|
United States | 17 | 2024 | 73186 | 0.140 |
Why?
|
Suppositories | 1 | 2016 | 16 | 0.130 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2018 | 354 | 0.130 |
Why?
|
Melena | 1 | 2015 | 32 | 0.130 |
Why?
|
Seroepidemiologic Studies | 2 | 2017 | 405 | 0.130 |
Why?
|
Fluorocarbons | 1 | 2021 | 506 | 0.130 |
Why?
|
End Stage Liver Disease | 1 | 2020 | 370 | 0.130 |
Why?
|
Duodenum | 1 | 2019 | 495 | 0.130 |
Why?
|
Cost-Benefit Analysis | 2 | 2021 | 5544 | 0.130 |
Why?
|
Reproductive History | 2 | 2018 | 210 | 0.130 |
Why?
|
Enema | 1 | 2016 | 141 | 0.130 |
Why?
|
Follow-Up Studies | 15 | 2023 | 39394 | 0.130 |
Why?
|
Appointments and Schedules | 1 | 2019 | 443 | 0.120 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 251 | 0.120 |
Why?
|
Androgens | 1 | 2022 | 1285 | 0.120 |
Why?
|
Capsule Endoscopy | 1 | 2015 | 106 | 0.120 |
Why?
|
Colon, Ascending | 1 | 2014 | 14 | 0.120 |
Why?
|
Smoking | 6 | 2022 | 9094 | 0.120 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 590 | 0.110 |
Why?
|
Anesthesia Department, Hospital | 1 | 2014 | 69 | 0.110 |
Why?
|
Multivariate Analysis | 6 | 2017 | 12095 | 0.110 |
Why?
|
Topography, Medical | 1 | 2013 | 37 | 0.110 |
Why?
|
Nurses | 2 | 2021 | 2501 | 0.110 |
Why?
|
Young Adult | 10 | 2020 | 60131 | 0.110 |
Why?
|
MutS Homolog 2 Protein | 1 | 2014 | 200 | 0.110 |
Why?
|
Risk Assessment | 10 | 2020 | 24333 | 0.110 |
Why?
|
Postoperative Complications | 1 | 2016 | 15889 | 0.110 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2014 | 97 | 0.110 |
Why?
|
Health Surveys | 7 | 2018 | 4055 | 0.110 |
Why?
|
Dietary Fiber | 2 | 2015 | 767 | 0.100 |
Why?
|
Medical Records | 1 | 2018 | 1411 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 3813 | 0.100 |
Why?
|
Patient Care Management | 1 | 2016 | 304 | 0.100 |
Why?
|
Boston | 3 | 2017 | 9377 | 0.100 |
Why?
|
Alcohol Drinking | 2 | 2022 | 4045 | 0.100 |
Why?
|
Crowding | 1 | 2013 | 144 | 0.100 |
Why?
|
DNA Repair Enzymes | 1 | 2014 | 346 | 0.100 |
Why?
|
Databases, Factual | 2 | 2019 | 8094 | 0.100 |
Why?
|
Hemodynamics | 1 | 2022 | 4199 | 0.100 |
Why?
|
Zinc | 1 | 2015 | 677 | 0.090 |
Why?
|
Adolescent | 9 | 2020 | 89244 | 0.090 |
Why?
|
Viral Load | 2 | 2018 | 3398 | 0.090 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2041 | 0.090 |
Why?
|
DNA Mismatch Repair | 1 | 2014 | 432 | 0.090 |
Why?
|
Feeding Behavior | 2 | 2020 | 3205 | 0.090 |
Why?
|
Electronic Mail | 1 | 2012 | 215 | 0.090 |
Why?
|
Colitis | 1 | 2019 | 1242 | 0.090 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 524 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2018 | 1813 | 0.090 |
Why?
|
Attitude to Computers | 1 | 2011 | 196 | 0.090 |
Why?
|
Chronic Disease | 4 | 2022 | 9384 | 0.090 |
Why?
|
Cohort Studies | 9 | 2022 | 41808 | 0.090 |
Why?
|
Educational Status | 1 | 2017 | 2515 | 0.080 |
Why?
|
Diet | 3 | 2021 | 8088 | 0.080 |
Why?
|
Adenosine Triphosphatases | 1 | 2014 | 842 | 0.080 |
Why?
|
Program Evaluation | 1 | 2018 | 2508 | 0.080 |
Why?
|
Fatty Acids | 1 | 2017 | 1812 | 0.080 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 906 | 0.080 |
Why?
|
Informed Consent | 1 | 2016 | 1010 | 0.080 |
Why?
|
Testosterone | 2 | 2022 | 2493 | 0.080 |
Why?
|
Rectum | 1 | 2014 | 900 | 0.080 |
Why?
|
ras Proteins | 1 | 2014 | 1058 | 0.080 |
Why?
|
Weight Gain | 1 | 2018 | 2359 | 0.080 |
Why?
|
Case-Control Studies | 7 | 2022 | 22296 | 0.080 |
Why?
|
HIV-1 | 2 | 2018 | 6962 | 0.070 |
Why?
|
Administration, Oral | 1 | 2016 | 4040 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10633 | 0.070 |
Why?
|
Logistic Models | 3 | 2017 | 13318 | 0.070 |
Why?
|
Self Report | 4 | 2024 | 3773 | 0.070 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2007 | 100 | 0.070 |
Why?
|
Bile Duct Diseases | 1 | 2007 | 98 | 0.070 |
Why?
|
Anemia | 1 | 2015 | 1517 | 0.070 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1769 | 0.060 |
Why?
|
Patient Admission | 1 | 2013 | 1370 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2016 | 3232 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6320 | 0.060 |
Why?
|
Immunoglobulin G | 2 | 2017 | 4568 | 0.060 |
Why?
|
Bile Ducts | 1 | 2007 | 288 | 0.060 |
Why?
|
Carcinoma | 1 | 2017 | 2340 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2784 | 0.060 |
Why?
|
Stomach Neoplasms | 1 | 2015 | 1483 | 0.060 |
Why?
|
Community Health Centers | 1 | 2009 | 469 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15471 | 0.060 |
Why?
|
Pancreatic Ducts | 1 | 2007 | 330 | 0.060 |
Why?
|
Decision Making | 3 | 2024 | 3953 | 0.060 |
Why?
|
Pancreatic Diseases | 1 | 2007 | 353 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 2884 | 0.060 |
Why?
|
Obesity | 2 | 2018 | 13091 | 0.060 |
Why?
|
Maine | 1 | 2024 | 146 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4607 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2059 | 0.060 |
Why?
|
Patient Participation | 2 | 2024 | 1448 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3859 | 0.060 |
Why?
|
HIV Infections | 3 | 2018 | 17591 | 0.060 |
Why?
|
Bone Marrow | 1 | 2014 | 2936 | 0.050 |
Why?
|
Motor Activity | 1 | 2013 | 2713 | 0.050 |
Why?
|
Lymphocyte Count | 2 | 2018 | 794 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3709 | 0.050 |
Why?
|
Feces | 2 | 2020 | 1510 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5801 | 0.050 |
Why?
|
Inflammation | 2 | 2020 | 10868 | 0.050 |
Why?
|
Genotype | 2 | 2014 | 13048 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2011 | 1388 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4528 | 0.050 |
Why?
|
Gastrointestinal Transit | 1 | 2022 | 101 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2012 | 5323 | 0.050 |
Why?
|
Reminder Systems | 1 | 2024 | 388 | 0.050 |
Why?
|
Prognosis | 2 | 2019 | 30046 | 0.050 |
Why?
|
Healthcare Disparities | 2 | 2013 | 3421 | 0.040 |
Why?
|
Anticoagulants | 1 | 2015 | 4850 | 0.040 |
Why?
|
Body Mass Index | 5 | 2018 | 13055 | 0.040 |
Why?
|
DNA Methylation | 1 | 2014 | 4432 | 0.040 |
Why?
|
Manometry | 1 | 2022 | 459 | 0.040 |
Why?
|
Inflammation Mediators | 2 | 2018 | 1890 | 0.040 |
Why?
|
Uncertainty | 1 | 2024 | 769 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2011 | 2336 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2339 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2012 | 3116 | 0.040 |
Why?
|
Sleep | 1 | 2014 | 4820 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2012 | 4651 | 0.040 |
Why?
|
Vitamin D | 1 | 2011 | 3311 | 0.040 |
Why?
|
Clinical Competence | 1 | 2013 | 4860 | 0.040 |
Why?
|
Schools | 2 | 2017 | 1498 | 0.040 |
Why?
|
Constipation | 1 | 2022 | 570 | 0.040 |
Why?
|
Efficiency | 1 | 2020 | 480 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2014 | 7885 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9618 | 0.030 |
Why?
|
Metagenomics | 1 | 2020 | 474 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 26395 | 0.030 |
Why?
|
Prostaglandins | 1 | 2017 | 398 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 1048 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2013 | 5522 | 0.030 |
Why?
|
Child Abuse | 1 | 2024 | 1091 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2011 | 4363 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 1952 | 0.030 |
Why?
|
Colectomy | 1 | 2020 | 699 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2020 | 12467 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1143 | 0.030 |
Why?
|
Internal Medicine | 1 | 2021 | 1064 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2008 | 3235 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2018 | 1866 | 0.030 |
Why?
|
Risk | 2 | 2018 | 9621 | 0.030 |
Why?
|
Smoking Cessation | 2 | 2018 | 2085 | 0.030 |
Why?
|
Splenomegaly | 1 | 2014 | 192 | 0.030 |
Why?
|
Cytokines | 2 | 2018 | 7453 | 0.030 |
Why?
|
Depression | 1 | 2012 | 8231 | 0.030 |
Why?
|
Plasma | 1 | 2016 | 585 | 0.030 |
Why?
|
Seafood | 1 | 2015 | 395 | 0.030 |
Why?
|
Micromanipulation | 1 | 2012 | 53 | 0.020 |
Why?
|
Marital Status | 1 | 2013 | 426 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8749 | 0.020 |
Why?
|
Cytarabine | 1 | 2014 | 697 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2018 | 1378 | 0.020 |
Why?
|
Age Factors | 3 | 2013 | 18435 | 0.020 |
Why?
|
Massachusetts | 1 | 2024 | 8894 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2017 | 65480 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1445 | 0.020 |
Why?
|
Virus Replication | 1 | 2018 | 2458 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2024 | 3269 | 0.020 |
Why?
|
Women | 1 | 2012 | 225 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 2012 | 446 | 0.020 |
Why?
|
New England | 1 | 2013 | 1058 | 0.020 |
Why?
|
Diuretics | 1 | 2013 | 614 | 0.020 |
Why?
|
Menopause | 1 | 2018 | 1656 | 0.020 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2014 | 647 | 0.020 |
Why?
|
Fruit | 1 | 2015 | 1165 | 0.020 |
Why?
|
Vegetables | 1 | 2015 | 1199 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 1469 | 0.020 |
Why?
|
Geography | 1 | 2012 | 654 | 0.020 |
Why?
|
Stomach | 1 | 2014 | 702 | 0.020 |
Why?
|
Eosinophilia | 1 | 2014 | 556 | 0.020 |
Why?
|
Women's Health | 1 | 2019 | 2081 | 0.020 |
Why?
|
Caregivers | 1 | 2020 | 2308 | 0.020 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2015 | 957 | 0.020 |
Why?
|
Disease Progression | 2 | 2017 | 13674 | 0.020 |
Why?
|
Students | 1 | 2017 | 1744 | 0.020 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2012 | 446 | 0.020 |
Why?
|
Diarrhea | 1 | 2014 | 1320 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3952 | 0.020 |
Why?
|
Fatigue | 1 | 2014 | 1557 | 0.020 |
Why?
|
Eating | 1 | 2013 | 1542 | 0.020 |
Why?
|
Poverty Areas | 1 | 2008 | 269 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2012 | 4168 | 0.020 |
Why?
|
HLA Antigens | 1 | 2012 | 1336 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2013 | 14794 | 0.020 |
Why?
|
Nanotechnology | 1 | 2012 | 714 | 0.020 |
Why?
|
Age of Onset | 1 | 2013 | 3346 | 0.020 |
Why?
|
Epitopes | 1 | 2012 | 2529 | 0.020 |
Why?
|
Cultural Competency | 1 | 2008 | 303 | 0.010 |
Why?
|
HIV | 1 | 2012 | 1597 | 0.010 |
Why?
|
Birth Weight | 1 | 2013 | 2121 | 0.010 |
Why?
|
Breast Feeding | 1 | 2013 | 1364 | 0.010 |
Why?
|
Phenotype | 1 | 2022 | 16731 | 0.010 |
Why?
|
RNA, Viral | 1 | 2012 | 2871 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2012 | 3163 | 0.010 |
Why?
|
Postmenopause | 1 | 2012 | 2519 | 0.010 |
Why?
|
Infant, Premature | 1 | 2013 | 2123 | 0.010 |
Why?
|
Child | 2 | 2024 | 80960 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9684 | 0.010 |
Why?
|
Biopsy | 1 | 2014 | 6805 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2012 | 2121 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36556 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15879 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5906 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6214 | 0.010 |
Why?
|
Heart Diseases | 1 | 2014 | 2819 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 6002 | 0.010 |
Why?
|
Life Style | 1 | 2012 | 3931 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2008 | 2744 | 0.010 |
Why?
|
Urban Population | 1 | 2008 | 2046 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 13021 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 16053 | 0.010 |
Why?
|
Health Behavior | 1 | 2009 | 2649 | 0.010 |
Why?
|
Image Enhancement | 1 | 2007 | 2898 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23653 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 18068 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2014 | 5716 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 42683 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2012 | 10276 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 4056 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 26428 | 0.010 |
Why?
|